Extensive surgical and medical clinical expertise for gastrointestinal, pancreatic and hepatic diseases.

Extensive academic basic, translational and clinical research expertise with focus on neuro-endocrine physiology, pathology and pharmacology. 

Extensive experience and expertise for research and drug development (R&D) following more than 10 years employement in pharmaceutical companies (AstraZeneca and now Zealand Pharma) 

Gastrointestinal mucosa function in colorectal neoplasia; Gastrointestinal mucosa function in inflammatory bowel disease; Acute pancreatitis; Non-Alchoholic Steato-Hepatitis (NASH); Small Bowel Syndrome (SBS).

Novel pharmacological targets for prevention and treatment of colorectal neoplasia/cancer

Novel pharmacological targets for the treatment of inflammatory bowel disease

Novel pharmacological tragerts for the treatment of NASH and SBS

VP Gastroenterology R&D employee at Zealand Pharma, a Copenhagen-based biotech company, developing medicines for endocrine, gastrointestinal and pancreatic indications.